Amussen Hunsaker Associates LLC Has $5.22 Million Stake in Healthequity Inc (HQY)

Share on StockTwits

Amussen Hunsaker Associates LLC decreased its holdings in Healthequity Inc (NASDAQ:HQY) by 0.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 87,445 shares of the company’s stock after selling 181 shares during the period. Healthequity makes up about 4.4% of Amussen Hunsaker Associates LLC’s holdings, making the stock its 8th biggest holding. Amussen Hunsaker Associates LLC’s holdings in Healthequity were worth $5,216,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in the company. Deutsche Bank AG raised its holdings in Healthequity by 42.3% during the 3rd quarter. Deutsche Bank AG now owns 295,652 shares of the company’s stock valued at $27,910,000 after buying an additional 87,870 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in Healthequity by 24.2% during the 3rd quarter. Bank of New York Mellon Corp now owns 872,322 shares of the company’s stock valued at $82,357,000 after buying an additional 169,985 shares during the last quarter. Riverhead Capital Management LLC raised its holdings in Healthequity by 24.3% during the 3rd quarter. Riverhead Capital Management LLC now owns 23,400 shares of the company’s stock valued at $2,209,000 after buying an additional 4,571 shares during the last quarter. GAM Holding AG bought a new stake in Healthequity during the 3rd quarter valued at $226,000. Finally, Legacy Financial Advisors Inc. bought a new stake in Healthequity during the 4th quarter valued at $28,000. 96.26% of the stock is owned by institutional investors.

In related news, EVP Delano Ladd sold 6,875 shares of the stock in a transaction dated Wednesday, February 20th. The shares were sold at an average price of $78.00, for a total value of $536,250.00. Following the completion of the transaction, the executive vice president now directly owns 14,340 shares in the company, valued at approximately $1,118,520. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, VP Darcy G. Mott sold 4,000 shares of the stock in a transaction dated Tuesday, January 22nd. The shares were sold at an average price of $60.81, for a total transaction of $243,240.00. Following the sale, the vice president now directly owns 79,200 shares in the company, valued at $4,816,152. The disclosure for this sale can be found here. Over the last quarter, insiders sold 18,875 shares of company stock valued at $1,429,370. 4.00% of the stock is owned by company insiders.

A number of equities research analysts recently commented on the stock. Oppenheimer upped their price target on shares of Healthequity from $74.00 to $98.00 and gave the company an “outperform” rating in a report on Tuesday, March 19th. Bank of America upped their price objective on shares of Healthequity from $82.00 to $83.00 and gave the stock a “neutral” rating in a report on Tuesday, March 19th. KeyCorp upped their price objective on shares of Healthequity from $74.00 to $90.00 and gave the stock an “overweight” rating in a report on Tuesday, March 19th. Cantor Fitzgerald upped their price objective on shares of Healthequity from $83.00 to $90.00 and gave the stock an “overweight” rating in a report on Tuesday, March 19th. Finally, BidaskClub upgraded shares of Healthequity from a “buy” rating to a “strong-buy” rating in a report on Saturday, March 16th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company’s stock. Healthequity currently has a consensus rating of “Buy” and a consensus price target of $86.85.

Shares of Healthequity stock opened at $73.57 on Tuesday. The stock has a market capitalization of $4.60 billion, a P/E ratio of 77.44, a price-to-earnings-growth ratio of 2.53 and a beta of 1.72. Healthequity Inc has a 1 year low of $50.29 and a 1 year high of $101.58.

Healthequity (NASDAQ:HQY) last issued its quarterly earnings results on Monday, March 18th. The company reported $0.21 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.15 by $0.06. The company had revenue of $75.78 million during the quarter, compared to analyst estimates of $74.28 million. Healthequity had a net margin of 25.73% and a return on equity of 13.59%. Healthequity’s quarterly revenue was up 25.4% compared to the same quarter last year. During the same period last year, the business earned $0.09 EPS. On average, analysts anticipate that Healthequity Inc will post 0.94 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Amussen Hunsaker Associates LLC Has $5.22 Million Stake in Healthequity Inc (HQY)” was first posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this report on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The correct version of this report can be viewed at https://www.tickerreport.com/banking-finance/4249026/amussen-hunsaker-associates-llc-has-5-22-million-stake-in-healthequity-inc-hqy.html.

Healthequity Company Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

See Also: What is the Difference Between Common Shares and Convertible Shares?

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthequity Inc (NASDAQ:HQY).

Institutional Ownership by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

MassGrid  Trading Up 23.8% Over Last Week
MassGrid Trading Up 23.8% Over Last Week
Divi Exchange Token Hits 1-Day Volume of $0.00
Divi Exchange Token Hits 1-Day Volume of $0.00
EncryptoTel [WAVES]  Price Reaches $0.0077 on Major Exchanges
EncryptoTel [WAVES] Price Reaches $0.0077 on Major Exchanges
Pampa Energia S.A.  Receives $49.00 Consensus Target Price from Brokerages
Pampa Energia S.A. Receives $49.00 Consensus Target Price from Brokerages
Koninklijke Ahold  Receives $28.00 Average Price Target from Analysts
Koninklijke Ahold Receives $28.00 Average Price Target from Analysts
Brokerages Anticipate Rudolph Technologies Inc  Will Post Quarterly Sales of $59.27 Million
Brokerages Anticipate Rudolph Technologies Inc Will Post Quarterly Sales of $59.27 Million


© 2006-2019 Ticker Report